Organic Letters
Letter
Notes
Scheme 4. A Plausible Reaction Mechanism for the TfOH-
Promoted Trifluoroethylation/Cyclization of
Isothiocyanates
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the Wuhan University of Technology, the National
Natural Science Foundation of China (21602165), the
“Chutian Scholar” Program from Department of Education
of Hubei Province (China), the “Hundred Talent” Program of
Hubei Province (China), and the Chongqing Research
Program of Basic and Frontier Technology (cstc2017jcy-
jAX0303, cstc2018jcyjAX0106) for financial support.
REFERENCES
intermediate (6). Intramolecular Friedel−Crafts reaction
between the activated NCS moiety and the adjacent aryl ring
gives a cyclohexadienyl cation 7, which is probably the rate-
determining step of the reaction. Then deprotonation of 7 by
the −OTf anion proceeds quickly and affords a stable
thioamide 1′ or 4′. Finally, trifluoroethylation of the thioamide
intermediate 1′ or 4′ at the sulfur center by 2a followed by
aromatization furnishes the final product 3 or 5 within a few
minutes. Since there was no N-trifluoroethylated product
observed, the reaction at the nitrogen site could be excluded.
In conclusion, we have developed a convenient and efficient
method for the one-pot synthesis of trifluoroethylthiol
phenanthridines and 3,4-dihydroisoquinolines under transi-
tion-metal-free conditions. The cascade trifluoroethylation/
cyclization of 2-isothiocyanobiaryls and aryl alkyl isothiocya-
nates (1 and 4) with phenyl(2,2,2-trifluoroethyl)iodonium
triflate (2a) in CH2Cl2 in the presence of TfOH at 40 °C
afforded a variety of trifluoroethylthiolated phenanthridine and
3,4-dihydroisoquinoline derivatives (3 and 5) in good to
quantitative yields. The reactions were dramatically promoted
by TfOH; its absence led to only trace amounts of the desired
products. The control experiments suggested that phenan-
thridine-6(5H)-thiones and 3,4-dihydroisoquinoline-1(2H)-
thiones might be the key intermediates of the reactions,
respectively, when using TfOH as a promotor. This protocol is
the first report for the production of fluorinated phenan-
thridine and isoquinoline derivatives from isothiocyanates
without using transition metals. The reactions verified again
the powerful electrophilic trifluoroethylation reactivity of
aryl(2,2,2-trifluoroethyl)iodonium salts. Application of these
promising reagents in new trifluoroethylation reactions is
currently underway in our laboratory.
■
(1) (a) Ojima, I. Fluorine in Medicinal Chemistry and Chemical
Biology; Wiley-Blackwell, 2009. (b) Prakash Reddy, V. Organofluorine
Compounds in Biology and Medicine; Elsevier, 2015.
(2) (a) Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Acena, J. L.;
̃
Soloshonok, V. A.; Izawa, K.; Liu, H. Chem. Rev. 2016, 116, 422.
(b) Yerien, D. E.; Bonesi, S.; Postigo, A. Org. Biomol. Chem. 2016, 14,
8398. (c) Cavaliere, A.; Probst, K. C.; Westwell, A. D.; Slusarczyk, M.
Future Med. Chem. 2017, 9, 1809. (d) Meanwell, N. A. J. Med. Chem.
2018, 61, 5822.
(3) Selected examples: (a) van Oeveren, A.; Motamedi, M.; Mani,
N. S.; Marschke, K. B.; Lopez, F. J.; Schrader, W. T.; Negro-Vilar, A.;
́
Zhi, L. J. Med. Chem. 2006, 49, 6143. (b) Baker, M. T. WO
2008008492A2. (c) Xu, F.; Zacuto, M.; Yoshikawa, N.; Desmond, R.;
Hoerrner, S.; Itoh, T.; Journet, M.; Humphrey, G. R.; Cowden, C.;
Strotman, N.; Devine, P. J. Org. Chem. 2010, 75, 7829. (d) Gujjar, R.;
El Mazouni, F.; White, J.; Creason, S.; Shackleford, D. M.; Deng, X.;
Charman, W. N.; Bathurst, I.; Burrows, J.; Floyd, D. M.; Matthews,
D.; Buckner, F. S.; Charman, S. A.; Phillips, M. A.; Rathod, P. K. J.
Med. Chem. 2011, 54, 3935. (e) Vorberg, R.; Trapp, N.; Zimmerli, D.;
Wagner, B.; Fischer, H.; Kratochwil, N. A.; Kansy, M.; Carreira, E. M.;
Muller, K. ChemMedChem 2016, 11, 2216.
̈
(4) (a) Han, J.-B.; Hao, J.-H.; Zhang, C.-P.; Qin, H.-L. Curr. Org.
Chem. 2015, 19, 1554 and references cited therein . (b) Song, H.-X.;
Han, Q.-Y.; Zhao, C.-L.; Zhang, C.-P. Green Chem. 2018, 20, 1662.
(c) Uneyama, K.; Yamazaki, T. J. Fluorine Chem. 2017, 203, 3.
(5) (a) Zhu, M.; Han, X.; Fu, W.; Wang, Z.; Ji, B.; Hao, X.-Q.; Song,
M.-P.; Xu, C. J. Org. Chem. 2016, 81, 7282. (b) Zhang, X.; Yang, C.
Adv. Synth. Catal. 2015, 357, 2721. (c) Roh, G.-b.; Iqbal, N.; Cho, E.
Chin. J. Chem. 2016, 34, 459. (d) Yu, X.; Cohen, S. M. J. Am. Chem.
Soc. 2016, 138, 12320. (e) Yan, S.-Y.; Zhang, Z.-Z.; Shi, B.-F. Chem.
Commun. 2017, 53, 10287. (f) Zhang, Y.; Du, H.; Zhu, M.; Li, J.; Zou,
D.; Wu, Y.; Wu, Y. Tetrahedron Lett. 2017, 58, 880. (g) Zhang, H.;
Wang, H.-Y.; Luo, Y.; Chen, C.; Cao, Y.; Chen, P.; Guo, Y.-L.; Lan,
Y.; Liu, G. ACS Catal. 2018, 8, 2173. (h) Ohtsuka, Y.; Yamakawa, T.
J. Fluorine Chem. 2016, 185, 96. (i) Zhang, H.; Chen, P.; Liu, G.
Angew. Chem., Int. Ed. 2014, 53, 10174.
ASSOCIATED CONTENT
* Supporting Information
■
S
(6) (a) Luo, H.; Wu, G.; Zhang, Y.; Wang, J. Angew. Chem., Int. Ed.
2015, 54, 14503. (b) Han, E.-J.; Sun, Y.; Shen, Q.; Chen, Q.-Y.; Guo,
Y.; Huang, Y.-G. Org. Chem. Front. 2015, 2, 1379. (c) Fujiwara, Y.;
Dixon, J. A.; O’Hara, F.; Funder, E. D.; Dixon, D. D.; Rodriguez, R.
The Supporting Information is available free of charge on the
́
A.; Baxter, R. D.; Herle, B.; Sach, N.; Collins, M. R.; Ishihara, Y.;
Screening of the optimal reaction conditions, proce-
dures, characterization data, control experiments, NMR
Baran, P. S. Nature 2012, 492, 95. (d) Tang, X.-J.; Thomoson, C. S.;
Dolbier, W. R., Jr. Org. Lett. 2014, 16, 4594. (e) Andrews, K. G.;
Faizova, R.; Denton, R. M. Nat. Commun. 2017, 8, 15913.
(7) (a) Umemoto, T.; Gotoh, Y. J. Fluorine Chem. 1985, 28, 235.
(b) Umemoto, T.; Gotoh, Y. Bull. Chem. Soc. Jpn. 1991, 64, 2008.
(c) Montanari, V.; Resnati, G. Tetrahedron Lett. 1994, 35, 8015.
(d) DesMarteau, D. D.; Montanari, V. Chem. Commun. 1998, 2241.
(e) DesMarteau, D. D.; Montanari, V. Chem. Lett. 2000, 29, 1052.
(f) Zhang, J.; Martin, G. R.; DesMarteau, D. D. Chem. Commun. 2003,
2334. (g) Lu, C.; DesMarteau, D. D. Chem. Commun. 2008, 208.
(h) Lu, C.; VanDerveer, D.; DesMarteau, D. D. Org. Lett. 2008, 10,
5565.
AUTHOR INFORMATION
Corresponding Author
■
ORCID
D
Org. Lett. XXXX, XXX, XXX−XXX